Folfox-4 regimen in a single center unselected series of metastatic colorectal cancer patients

被引：0
|
作者：
Rampinelli, I [1 ]
Bucci, E [1 ]
Di Lucca, G [1 ]
Scaglietti, U [1 ]
Cererani, N [1 ]
Guffanti, M [1 ]
Zerini, D [1 ]
Verasio, C [1 ]
机构：
[1] Casa Cura S Maria, HSR, Unita Funz Oncol, Castellanza, VA, Italy
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
H49
引用
收藏
页码：73 / 73
页数：1
相关论文
共 50 条
  • [1] FOLFOX-4 Regimen as a First-line Therapy for Cuban Patients with Metastatic Colorectal Cancer
    Lami, Leonardo
    Areces, Fernando
    Lence, Juan J.
    Arbesu, Maria A.
    MEDICC REVIEW, 2009, 11 (03) : 34 - 38
  • [2] Dose intensity chemotherapy in adjuvant colorectal cancer with FOLFOX-4 regimen
    Evangelista, W.
    Racca, P.
    Fanchin, L.
    Ritorto, G.
    Volpatto, R.
    Ciorba, A.
    Facilissimo, I
    Napoletano, R.
    Bertetto, O.
    Ciuffreda, L.
    ANNALS OF ONCOLOGY, 2006, 17 : 39 - 39
  • [3] Second-line XELOX or FOLFOX-4 for metastatic colorectal cancer
    Ursina R. Teitelbaum
    Daniel G. Haller
    Nature Reviews Clinical Oncology, 2009, 6 : 250 - 251
  • [4] Second-line XELOX or FOLFOX-4 for metastatic colorectal cancer
    Teitelbaum, Ursina R.
    Haller, Daniel G.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (05) : 250 - 251
  • [5] Cetuximab and FOLFOX-4 in metastasized colorectal Cancer
    Kuetting, Fabian
    Alakus, Hakan
    Bruns, Christiane
    ONKOLOGE, 2018, 24 (12): : 1034 - 1036
  • [6] Retreatment with FOLFOX for patients with metastatic colorectal cancer-single center experience
    Marija, Ristic
    Nemanja, Stanic
    Dusan, Ristic
    Davorin, Radosavljevic
    Jelena, Spasic
    Vladimir, Nikolic
    ANNALS OF ONCOLOGY, 2017, 28
  • [7] A phase II study of gefitinib in combination with FOLFOX-4 (IFOX) in patients with metastatic colorectal cancer.
    Cho, CD
    Fisher, GA
    Halsey, J
    Jambalos, CN
    Schwartz, EJ
    Rouse, RV
    Advani, RH
    Wakelee, HA
    Lum, BL
    Sikic, BI
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6103S - 6103S
  • [8] A phase II study of gefitinib in combination with FOLFOX-4 (IFOX) in patients with metastatic colorectal cancer.
    Fishe, GA
    Kuo, T
    Cho, CD
    Halsey, J
    Jambalos, CN
    Schwartz, EJ
    Robert, RV
    Advani, RH
    Wakelee, HA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 248S - 248S
  • [9] Carcinoembryonic antigen in monitoring of response to cetuximab plus FOLFIRI or FOLFOX-4 in patients with metastatic colorectal cancer
    Tsai, H. L.
    Chang, Y. T.
    Chu, K. S.
    Chen, C. F.
    Yeh, Y. S.
    Ma, C. J.
    Wu, D. C.
    Kuo, C. H.
    Chan, H. M.
    Sheen, M. C.
    Wang, J. Y.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2008, 23 (04): : 244 - 248
  • [10] FOLFOX-4 REGIMEN AS ADJUVANT TREATMENT OF RADICALLY RESECATED GASTRIC CANCER PATIENTS
    Lucia, Cannella
    Alfonso, De Stefano
    Antonella, Prudente
    Carolina, Cimminiello
    Elide, Matano
    Roberto, Bianco
    Chiara, Carlomagno
    Anna, Crispo
    Sabino, De Placido
    ANNALS OF ONCOLOGY, 2009, 20
12345